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Suspected atherogenic activity of beta-blockers especially after a long-lasting usage and in 
patients with disturbed lipid metabolism presents still an unsolved problem, indeed. Evaluation 
of their action on lipid metabolism is complicated by numerous factors, e.g. the individual 
pharmacological characteristics of single representatives (sympathico-mimetic activity, 
cardioselectivity, membrane stabilizing effect), dosage, pathway and duration of application, 
combined application with other drugs, concentration of research on a limited number of 
parameters or lipid metabolism, etc. Studies of beta-blockers' effects on serum free fatty acids 
(FFAs) are commonly restricted to the determination of their total concentrations [3,5,6,9 a. oth.]. 
Our previous investigations [2] of serum levels of 8 FFAs in rats singly treated with propranolol 
showed a quantitatively differently expressed participation in the total reduction responding in 
three of these acids (C16:0, C18:l, and C18:2) to a linear dose- and time-dependence. 
In the present paper demonstrating a component of our investigation of the effect of the non-
selective beta-blocker propranolol on lipid metabolism the influence of this drug after repeated 
application on the serum levels of eight FFAs is followed-up. White male rats are used. The 
following FFAs are analyzed: myristic acid (C14:0), palmitic acid (C16:0), palmitoleic acid 
(C16:l), stearic acid (C18:0), oleic acid (C18:l), linoleic acid (C18:2), eicosantrienic acid (C20:3), 
and arachidonic acid (C20:4). 
MATERIAL AND METHODS 
The study covered 66 white male rats with b.w. between 130,0 and 160,0 g. Beta-blocker was 
intraperitoneally applied in a dose of 3 mg/kg b.w. two times daily for 20 days. Control animal 
group was treated by the same way for the same period with an equal volume of saline solution. 
Blood was taken on the 10 and 20 day after treatment by two ways: on the 2 and 16 hour 
after the last drug administration as well as on the 15* day after treatment cessation. Serum was 
extracted after Folsh's et al. method (1957). After thin-layer chromatography of lipid extract [1] 
FFAs were quantitatively isolated, methylated with diazomethane and gas-chromatographicadly 
estimated. 
RESULTS AND DISCUSSION 
It is established that under these experimental conditions propranolol reduces statistically 
significantly total FFAs on the 101 day after treatment. Its effect is slightly marked on the 20 
day (fig. 1). The comparison of the quantitative manifestation of the effect reveals its dependence 
on tie interval after the last treatment: on the 2 hour after the last application FFA level 
decrease&by 21 per cent while after an interval of 16 hours - by 14 per cent only. Most probably, 
on the 2 n hour the effect of the last propranolol dose is added to that of repeated beta-blocker 
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Fig. 1. Serum levels of total FFAs after propranolol administration for 20 days after cessation of 




о b a h 
10 days of 20 days of 15 days after the 
treatment treatment last treatment 
Fig. 2. Changes of serum levels of myristic acid afterpropranolol administration for 20 days and 
15 days after cessation of treatment: a)2h after the last application, and b) 16 h after it. 
Asterisks indicate statistically significant differences 
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Fig. 3. Changes of serum levels of linoleic acid afterpropranolol administration for 20 days and 
15 days after cessation oftreatment: a)2n after the last application, andb) 16 h after it. 
Astensks indicate significant differences 
application. This propranolol effect reduction in the course of its long-lasting administration (i.e. 
on the 20 day) found out by us is similar to that one reported by Lehtonen [6] as an initial, during 
the first month only, FFA level decrease in patients chronically treated with a cardioselective 
beta-blocker. The effect of the drug is completely exhausted on the 15th day after cessation of 
application. 
The participation of single FFAs in the total effect is quantitatively differently manifested: on 
the 10 day after a 2-h interval of examination there is the greatest reduction of C14:0 (by 38 per 
cent) followed by that of C16:l (by 32 per cent) and C16:0 (by 24,9 per cent). However, on the 
20* day the reduction of these FFAs is significantly less expressed, by 18 per cent, by 11,3 per 
cent and by 1,2 per cent, respectively. All changes are insignificant when a 16-h interval of 
examination is concerned. Similar behaviour of these three FFAs is illustrated on fig. 2 on the 
example of C14:0 concentration changes. 
Polyunsaturated fatty acids act by a different manner. On the 10 and 20 day after a 2-h interval 
after the last injection C18:2 concentration remains reduced by about 20 per cent. In our previous 
investigation [2] we established a significant reduction of this acid even after a single propranolol 
administration. As C18:2 reduction in some lipid classes is considered a risk factor in ischemic 
heart disease [7] these data seem to be of particular importance. However, on the 20 day after 
a 16-h interval after drug introduction C18:2 concentration is increased (fig. 3). 
Changes of arachidonic acid concentration differ from these of saturated and monoenic acids 
(fig. 4). In the course of propranolol treatment the level of this acid does not decrease significantly 
concerning any intervals examined and even increases on the 20l day. Having in mind the role 
of this acid as a prostaglandin precursor as well as data about its concentration increase in the 
myocardium under conditions of experimentally induced ischemia [8] this increase established 
by us on the 20 day after treatment has an essential importance for the characterization of 
propranolol influence on serum FFA levels. 
Tnere are similar changes of C20:3 concentration which increases on the 10 and 20 day after 
treatment. 
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Fig. 4. Changes of serum levels of arachidonic acid afterpropranolol administration for 20 days 
and 15 days after cessation of treatment: a)2n after the last application, andb) 16 h after 
it. Asterisks indicate statistical differences 
These differences in the behaviour of polyunsaturated FFAs, on the one hand, and of saturated 
and monounsaturated ones, on the other hand, in the course of long-lasting propranolol 
application enable us to suggest a different significance of the beta-adrenergic blockade for the 
lipolysis of these two FFA groups. Our previous studies concerning single propranolol application 
also direct our attention to a probably different role of beta-adrenergic control of lipolysis of 
individual FFAs [2]. In both cases, propranolol effect on individual FFA lipolysis is not an uniform 
one and thus requires its follow-up in the rest Upid classes - triacylglycerols, phospholipids, 
cholesterol esters, etc. It seems especially important to follow-up the concentration changes of 
polyenic acids, particularly of C20:4 as well as of C20:3 / C20:4 ratio being an important parameter 
m cases of an essential-fatty-acid deficit. Having in mind the most commonly rather long duration 
of beta-blocker therapy we suggest the pur posef illness of the follow-up of these changes for a 
longer period of propranolol application. 
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Р Е З Ю М Е 
Авторами прослеживается эффект многократного применения пропранолола на сывороточный уровень 
восьми свободных жирных кислот. Бета блокер применяется интраперитонеально в дозе 3 мг/кг 2 раза в день в 
течение 20 дней. Уровень свободных жирных кислот определялся на 10 и 20 дни с начала введения (2 и 16 часов 
после последнего введения) и на 15 день после остановки его введения посредством газ-жидкой хроматографии. 
На 10-тый день было установлено уменьшение тотального количества свободных жирных кислот. Эффект 
редуцирован на 20-тый день и вполне отсуствует на 15-тый день после прекращения введения. Участие 
индивидуальных свободных жирных кислот неодинаково в количественном отношении. Относительную 
стабильность показывает арахидоновая кислота, количество которой возрастает на 20-тый день. Обсуждаются 
различия в влиянии пропранолола на липолиз индивидуальных свободных жирных кислот. 
